Kristie Blum, MD
Emory University Hospital/Winship Cancer Institute · Ohio State University Comprehensive Cancer Center · Ohio State University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kristie Blum, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05039073 · Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint InhibitorsEmory University · recruiting · Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma · principal investigator
- Ph2NCT01812005 · Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaOhio State University Comprehensive Cancer Center · terminated · Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma · principal investigator
- Ph2NCT01460940 · A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's LymphomaOhio State University Comprehensive Cancer Center · completed · Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma · principal investigator
- Ph2NCT00201877 · Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's LymphomaOhio State University Comprehensive Cancer Center · completed · Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · fiscal years 2009 to 2026Named on NCT05039073
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.